Meningeoomien ilmaantuvuus Suomessa 1990-2017
Ekqvist, Olli (2023)
2023
Lääketieteen lisensiaatin tutkinto-ohjelma - Licentiate's Programme in Medicine
Lääketieteen ja terveysteknologian tiedekunta - Faculty of Medicine and Health Technology
This publication is copyrighted. Only for Your own personal use. Commercial use is prohibited.
Hyväksymispäivämäärä
2023-02-16
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202302122294
https://urn.fi/URN:NBN:fi:tuni-202302122294
Tiivistelmä
Meningiomas are the most common primary neoplasm of the central nervous system. Previous research on incidence on meningioma in Finland showed an increase in age-standardized incidence rate over three decades (1968–1997). In this study, we analysed meningioma incidence in Finland during 1990–2017.
Data on 9842 meningioma patients were obtained from the Finnish Cancer Registry and population size by calendar year, sex and age group from Statistics Finland. European Standard Population was used to calculate age-standardized incidence rates. Poisson regression was used to evaluate differences by sex and age and joinpoint regression to examine changes in trend.
At the beginning of the study period age-standardized incidence of meningioma for men and women was 2.35/100,000 and 6.96/100,000, and at the end it was 4.09/100,000 and 10.19/100,000, respectively. Annual percent change (APC) for women was +4.6 (95% CI 3.10 to 6.20) 1990–2001 and -1.0 (95% CI -1.70 to -0.30) 2001–2017. From 1990 to 2002 the APC for men was +3.1 (95% CI 0.80 to 5.40) and from 2002 to 2017 -0.9 (95% CI -2.10 to 0.30). Meningioma incidence in women was 2.8 times higher than for men (RR 2.81; 95% CI 2.68–2.94).
Meningioma incidence increased in both sexes from 1990, but the trend was reversed in 2001–2002.
Data on 9842 meningioma patients were obtained from the Finnish Cancer Registry and population size by calendar year, sex and age group from Statistics Finland. European Standard Population was used to calculate age-standardized incidence rates. Poisson regression was used to evaluate differences by sex and age and joinpoint regression to examine changes in trend.
At the beginning of the study period age-standardized incidence of meningioma for men and women was 2.35/100,000 and 6.96/100,000, and at the end it was 4.09/100,000 and 10.19/100,000, respectively. Annual percent change (APC) for women was +4.6 (95% CI 3.10 to 6.20) 1990–2001 and -1.0 (95% CI -1.70 to -0.30) 2001–2017. From 1990 to 2002 the APC for men was +3.1 (95% CI 0.80 to 5.40) and from 2002 to 2017 -0.9 (95% CI -2.10 to 0.30). Meningioma incidence in women was 2.8 times higher than for men (RR 2.81; 95% CI 2.68–2.94).
Meningioma incidence increased in both sexes from 1990, but the trend was reversed in 2001–2002.